Cite
HARVARD Citation
Peek, J. et al. (2018). Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism. Nature communications. 9 (1), pp. 1-15. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Peek, J. et al. (2018). Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism. Nature communications. 9 (1), pp. 1-15. [Online].